Sarcouncil Journal of Applied Sciences Aims & Scope

Abstract: Erectile dysfunction & painful erections may be linked to Peyronie's disease, an acquired injury in the tunica albuginea represented by the growth of a fibrous tissue plaque. The purpose of this study was to evaluate the safety, efficacy, and satisfaction of patients with Peyronie's disease after receiving focused shock wave treatment. Thirty patients having Peyronie's disease participated in an open-label, single-arm, prospective trial following giving their informed permission. The International Erectile Function Index-5 score, patient demographics, lesion hardness and penile curvature modifications, and overall satisfaction rate were all noted. The Peyronie's plaque is treated with 3000 focused shock waves over the course of 20 minutes, once a week for six weeks. Thirty patients in all, with an average age of fifty, were enrolled in the research over the course of a year. After 33 years, dorsal site curvatures as well as fibrous plaque were the most prevalent. Around two-thirds stated having penile curvature for less than a year, with the majority having greater degrees (30°–60°), and around one-third reported feeling penile discomfort during an erection. When using focused shock wave treatment. After six weeks of follow-up, the majority of patients who had focused shock wave therapy showed significant improvements in their sexual function, as well as alterations to their penile curvature, plaque size, and discomfort, with identical results at the three-month mark. Focal shock wave therapy seems to be extremely safe, highly effective in reducing pain along with penile curvature, preserving penile length, and linked to the highest patient satisfaction rate in these short-term studies in a carefully chosen group of people with Peyronie's disease characteristics.